Laurus Labs Ltd.
Snapshot View

585.05 +7.75 ▲1.3%

17 August 2022, 10:25:57 AM
Volume: 523,103

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.lauruslabs.com
Market Cap 31,027.13 Cr.
Enterprise Value(EV) 32,683.22 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 15.58 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 37.05 Trailing Twelve Months Ending 2022-06
Industry PE 32.22 Trailing Twelve Months Ending 2022-06
Book Value / Share 66.89 Trailing Twelve Months Ending 2022-06
Price to Book Value 8.63 Calculated using Price: 577.40
Dividend Yield 0.35 Period Ending 2022-03
No. of Shares Subscribed 53.74 Cr. 537,359,335 Shares
FaceValue 2
Company Profile
Laurus Labs offers broad and integrated portfolio of Active Pharma Ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical industry. Their major focus areas include anti-retroviral, Hepatitis C and Oncology drugs.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.34%
1 Week
+4.69%
1 Month
+11.95%
3 Month
+4.62%
6 Month
+6.51%
1 Year
-15.80%
2 Year
+180.12%
5 Year
+436.94%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 33.42 14.47 18.65 18.12 11.97 6.19 15.39 45.15 28.05
Return on Capital Employed (%) 19.96 13.74 16.35 16.52 13.68 8.22 14.14 39.82 25.97
Return on Assets (%) 7.64 4.31 6.61 8.05 6.04 3.00 7.34 20.87 13.09

Balance Sheet View Details >>

Particulars 9 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 358 722 857 1,330 1,483 1,558 1,770 2,598 3,351
Non Curr. Liab. 204 364 428 132 174 295 214 693 928
Curr. Liab. 711 802 884 1,121 1,307 1,424 1,692 2,457 2,681
Minority Int. 3 8
Equity & Liab. 1,273 1,888 2,169 2,584 2,964 3,278 3,676 5,751 6,968
Non Curr. Assets 697 1,024 1,166 1,444 1,716 1,815 1,864 2,676 3,623
Curr. Assets 575 862 1,003 1,140 1,248 1,463 1,812 3,075 3,345
Misc. Exp. not W/O 2 2
Total Assets 1,273 1,888 2,169 2,584 2,964 3,278 3,676 5,751 6,968

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 1,160 1,327 1,778 1,905 2,056 2,292 2,832 4,814 4,936 5,196
Other Income 9 34 4 33 29 16 6 24 15 11
Total Income 1,169 1,361 1,782 1,938 2,085 2,308 2,838 4,837 4,951 5,207
Total Expenditure -956 -1,131 -1,415 -1,497 -1,643 -1,936 -2,267 -3,263 -3,513 -3,715
PBIDT 212 229 367 441 443 372 570 1,574 1,438 1,492
Interest -59 -101 -111 -100 -80 -88 -90 -68 -102 -105
Depreciation -33 -62 -86 -106 -125 -164 -187 -205 -251 -264
Taxation -24 2 -35 -44 -70 -26 -38 -317 -251 -280
Exceptional Items
PAT 97 68 134 191 168 94 255 984 832 843
Minority Interest 0 -5 -5
Share Associate 0 0 -1 0 -1
Other Related Items
Consolidated Net Profit 97 68 134 190 168 94 255 984 828 837
Adjusted EPS 13 9 17 4 3 2 5 18 15 16

Cash Flow View Details >>

Particulars 9 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 121 -65 182 332 342 298 347 733 911
Cash Fr. Inv. -312 -397 -312 -289 -384 -253 -221 -941 -914
Cash Fr. Finan. 203 486 103 -54 42 -45 -128 255 30
Net Change 12 24 -27 -10 1 0 -1 47 27
Cash & Cash Eqvt 15 40 13 2 3 3 2 48 75

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 32.13 32.12 28.76 27.45 27.30 27.30 27.27 27.27 27.27
Public 67.87 67.88 71.24 72.55 72.70 72.70 72.73 72.73 72.73
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 31.56 16.42 15.76 1.15 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 03 Aug 2022
Transcript of Analysts/Institutional Investor Meet/Con. Call
Laurus Labs Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call
Tue, 02 Aug 2022
Transcript of Analysts/Institutional Investor Meet/Con. Call
Laurus Labs Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call
Fri, 29 Jul 2022
Recording of Analysts/Institutional Investor Meet/Con. Call
Laurus Labs Limited has informed the Exchange about Recording of Analysts/Institutional Investor Meet/Con. Call

Technical Scans View Details >>

Tue, 16 Aug 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week High Close Crossing Last Week High
Opening at Low Opening at Low

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,443.18 919.80 +0.6%
Divi's Laboratories Ltd. 99,072.87 3,771.80 +1.1%
Cipla Ltd. 83,487.41 1,031.70 -0.3%
Dr. Reddy's Laboratories Ltd. 71,536.21 4,315.30 +0.4%
Apollo Hospitals Enterprise Ltd. 62,537.70 4,326.35 -0.5%
Torrent Pharmaceuticals Ltd. 53,261.16 1,562.45 -0.7%
Piramal Enterprises Ltd. 45,983.34 1,980.90 +2.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.42 919.80 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-06 31.92 3,771.80 +1.1%
Cipla Ltd. Consolidated 2022-06 33.44 1,031.70 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.91 4,315.30 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.76 4,326.35 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 66.33 1,562.45 -0.7%
Piramal Enterprises Ltd. Consolidated 2022-06 24.47 1,980.90 +2.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.38 919.80 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,771.80 +1.1%
Cipla Ltd. Consolidated 2022-06 3.87 1,031.70 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.53 4,315.30 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.52 4,326.35 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.31 1,562.45 -0.7%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,980.90 +2.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 919.80 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,771.80 +1.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,031.70 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,315.30 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,326.35 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,562.45 -0.7%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,980.90 +2.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 919.80 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,771.80 +1.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.70 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,315.30 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,326.35 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,562.45 -0.7%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,980.90 +2.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 919.80 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,771.80 +1.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.70 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,315.30 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,326.35 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,562.45 -0.7%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,980.90 +2.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 919.80 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,771.80 +1.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,031.70 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,315.30 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,326.35 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,562.45 -0.7%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,980.90 +2.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 919.80 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,771.80 +1.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,031.70 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,315.30 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,326.35 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,562.45 -0.7%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,980.90 +2.8%

FAQ's On Laurus Labs Ltd.

Can I Buy Laurus Labs Shares now?

What is the Share Price of Laurus Labs?

What is the Relative Strength Index (RSI) Value of Laurus Labs?

What is the Market Capital (MCAP) of Laurus Labs?

What are the key metrics to analyse Laurus Labs?

What is the Price Performance of Laurus Labs?